Clinical Use and Hemostatic Application of Gelatin

  • Roberto GazzeriEmail author
  • Marcelo Galarza
  • Marika Morabito
  • Alex Alfieri
Part of the Gels Horizons: From Science to Smart Materials book series (GHFSSM)


Because of the potentially devastating consequences, adequate hemostasis is of paramount importance in all surgical procedures: generalized ooze hemorrhage from the surgical wall cavities, arising from the surface of different organs as liver, kidney, or nervous tissue, can result in considerable blood loss, prolonging surgical times, and with major risk for infection and mortality. Furthermore, hemorrhage may limit visualization in a confined operative field of view, as during endoscopic approaches. Blood-sparing procedures are required for blood loss control to arrest bleeding-related issues and the need for blood transfusions. Classical blood-sparing techniques, such as electrocauterization of the vessels and suturing, are in some cases ineffective. Matrix hemostatic agents are a mixture of a gelatin matrix (bovine or porcine) and a thrombin component mixed together at the time of use. Both components interact synergistically to raise hemostasis and make possible the development of the clot at the bleeding area. In this study, we compare the different hemostatic techniques using the gelatin hemostatic matrix sealant, investigating and reviewing its efficacy and safety in all surgical subspecialties.


  1. Aguilar Palacios D, Mcdonald M, Miyake M, Rosser CJ (2013) Pilot study comparing the two hemostatic agents in patients undergoing partial nephrectomy. BMC Res Notes 6:399–403 Google Scholar
  2. Ahlering TE, Eichel L, Chou D, Skarecky DW (2005) feasibility study for robotic radical prostatectomy cautery-free neurovascular bundle preservation. Urology 65(5):994–997PubMedCrossRefGoogle Scholar
  3. Angioli R, Muzii L, Montera R, Damiani P, Bellati F, Plotti F, Zullo MA, Oronzi I, Terranova C, Benedetti Pacini P (2009) Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma. J Minim Invasive Gynecol 16(2):153–156PubMedCrossRefGoogle Scholar
  4. Antisdel JL, Janney CG, Long JP, Sindwani R (2008) Hemostatic agent microporous polysaccharide hemospheres (MPH) does not affect healing or Intact sinus mucosa. Laryngoscope 118:1265–1269PubMedCrossRefGoogle Scholar
  5. Antonelli A, Minervini A, Mari A, Bertolo R, Bianchi G, Lapini A, Longo N, Martorana G, Mirone V, Morgia G, Novara G, Porpiglia F, Rocco B, Rovereto B, Schiavina R, Simeone C, Sodano M, Terrone C, Ficarra V, Carini M, Serni S, members of the RECORD project-LUNA foundation (2015) TriMatch comparison of the efficacy of Floseal versus Tachosil versus no hemostatic agents for partial nephrectomy: results from a large multicenter dataset. International J Urol 22:47–52Google Scholar
  6. Baumann A, Caversaccio M (2003) Hemostasis in endoscopic sinus surgery using a specific gelatin-thrombin based agent (FloSeal™). Rhinology 41:244–249PubMedGoogle Scholar
  7. Bedi DA, Toms SA, Dehdashti AR (2011) Use of hemostatic matrix for hemostasis of the cavernous sinus during endoscopic endonasal pituitary and suprasellar tumor surgery. Skull Base 21(3):189–192PubMedPubMedCentralCrossRefGoogle Scholar
  8. Benedetto F, Passari G, Stilo F, La Spada M, Cotroneo A, Lentini S, Spinelli F (2010) Use of FloSeal in the endovascular treatment of voluminous aneurysm of a lower gluteus artery. Minerva Chir 65(1):117–121PubMedGoogle Scholar
  9. Benito J, Abraham A, Gamboa AJR, Finley DS, Beck SM, Lee HJ, Santos RJS, Box GN, Deane LA, Vajgrt DJ, McDougall EM, Clayman RV (2009) The UCI Seldinger technique for percutaneous renal cryoablation: protecting the tract and achieving hemostasis. J Endourol 23(1):43–49CrossRefGoogle Scholar
  10. Berrevoet F, De Hemptinne B (2007) Use of topical hemostatic agents during liver resection. Dige Surg 24:288–293CrossRefGoogle Scholar
  11. Beyea JA, Rotenberg BW (2011) Comparison of purified plant polysaccharide (HemoStase) versus Gelatin-Thrombin matrix (FloSeal) in controlling bleeding during sinus surgery: a randomized controlled trial. Ann Otol Rhinol Laryngol 120(8):495–498PubMedCrossRefGoogle Scholar
  12. Bhayani SB, Grubb RL III, Andriole GL (2002) Use of gelatin matrix to rapidly repair diaphragmatic injury during laparoscopy. Urology 60(3):514i–514iiCrossRefGoogle Scholar
  13. Björses K, Holst J (2009) Topical haemostatics in renal trauma—an evaluation of four different substances in an experimental setting. J Trauma 66:602–611PubMedCrossRefGoogle Scholar
  14. Blackmore KJ, O’Hara J, Flood LM, Martin FW (2008) The effect of Floseal on post-tonsillectomy pain: a randomized controlled pilot study. Clin Otolaryngol 33:265–284CrossRefGoogle Scholar
  15. Borges Santos M, Silva S, Bettencourt V, Campante Teles R, Souse Almeida M, Medeiros D, Aniceto Silva J (2012) Ultrasound-guided- thrombin-gelatin injection is effective for the treatment of iatrogenic femoral artery pseudoaneurysms: initial results. Catheter Cardiovasc IntervGoogle Scholar
  16. Borin JF, Sala LG, Eichel L, McDougall EM, Clayman RV (2005) Tubeless percutaneous nephrolithotomy using hemostatic gelatin matrix. J Endourol 19(6):614–617PubMedCrossRefGoogle Scholar
  17. Brandes SB (2006) Editorial comment: “damage control management of experimental grade 5 renal injuries: further evaluation of Floseal gelatin matrix”. J Trauma 60:346–350CrossRefGoogle Scholar
  18. Breda A, Stepanian SV, Lam JS, Liao JC, Gill IS, Colombo JR, Guazzoni G, Stifelman MD, Perry KT, Celia A, Breda G, Fornara P, Jackman SV, Rosales A, Palou J, Grasso M, Pansadoro V, Disanto V, Porpiglia F, Milani C, Abbou CC, Gaston R, Janetschek G, Soomro NA, De la Rosette JJ, Laguna PM, Schulam PG (2007) Use of hemostatic agents and glues during laparoscopic partial nephrectomy: a multi-institutional survey from the united States and Europe of 1347 cases. Eur Urol 52:798–803PubMedCrossRefGoogle Scholar
  19. Buiret G, Pavic M, Pignat JC, Pasquet F (2013) Case Rep OtolaryngolGoogle Scholar
  20. Cappabianca P, Esposito F, Esposito I, Cavallo LM, Leone CA (2009) Use of a thrombin-gelatin haemostatic matrix in endoscopic endonasal extended approaches: technical note. Acta Neurochir 151(1):69–77PubMedCrossRefGoogle Scholar
  21. Carnaghan HK, Harrison MR (2009) Presealing of the chorioamniotic membranes prior to fetoscopic surgery: preliminal study with unfertilized chicken egg models. Eur J Obstet Gynecol Reprod Biol 144:142–145CrossRefGoogle Scholar
  22. Celia A, Zeccolini G, Guazzoni G, Pansadoro V, Disanto V, Porpiglia F, Milani C, Abou C, Gaston R, Janetschek G, Soomro NA, Fornara P, Breda A, Schulam PG, De La Rosette J, Laguna MP, Palou J, Breda G (2008) laparoscopic nephron sparing surgery: a multi-institutional European survey of 592 cases. Archivio Italiano di urologia e andrologia 80(3):85–91PubMedGoogle Scholar
  23. Chandra RK, Conley DB, Kern RC (2003) The effect of Floseal on mucosal healing after endoscopic sinus surgery: a comparison with Thrombin-soaked gelatin foam. Am J Rhinol 17(1):51–55PubMedCrossRefGoogle Scholar
  24. Chandra RK, Conley DB, Haines GK III, Kern RC (2005) Long-term effects of FloSeal™ packing after endoscopic sinus surgery. Am J Rhinol 19(3):240–243PubMedCrossRefGoogle Scholar
  25. Clapp M, Huang JC (2013) Use of floseal sealant in the surgical management of tubal ectopic pregnancy. Case Rep Obstet GynecolGoogle Scholar
  26. Côté D, Barber B, Diamond C, Wright E (2010) FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial. J Otolaryngol-Head Neck Surg 39(3):304–308PubMedGoogle Scholar
  27. Derweesh IH, Malcolm JB, Diblasio CJ, Mehrazin R, Jackson S (2008) Sutureless laparoscopic heminephrectomy: safety and efficacy in physiologic and chronically obstructed porcine kidney. Surg Innov 15(3):194–202PubMedCrossRefGoogle Scholar
  28. Dhillon S (2011) Fibrin Sealant (Evicel® [Quixil®/Crosseal™]) A review of its use as supportive treatment for hemostasis in surgery. Drugs 71(14):1893–1915PubMedCrossRefGoogle Scholar
  29. Duranni OM, Fernando AI, Reuser TQ (2007) Use of a novel topical hemostatic sealant in lacrimal surgery: a prospective, comparative study. Ophthalmic Plast Reconstr Surg 23(1):25–27CrossRefGoogle Scholar
  30. Ebert AD, Hollauer A, Fuhr N, Langolf O, Papadopoulos T (2009) Laparoscopic ovarian cystectomy without bipolar coagulation or sutures using a gelatin-thrombin matrix sealant (FloSeal©): first support of a promising technique. Arch Gynecol Obstet 280:161–165PubMedCrossRefGoogle Scholar
  31. Echave M, Oyagüez I, Casado MA (2014) Use of Floseal®, a human gelatin-thrombin matrix sealant, in surgery: a systematic review. BMC Surg 14:111–123PubMedPubMedCentralCrossRefGoogle Scholar
  32. Ellegala DB, Maartens NF, Laws ER (2002) Use of Floseal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery 51(2):513–516PubMedCrossRefGoogle Scholar
  33. Ereth MH, Shaff M, Ericson EF, Wetjen NM, Nuttall GA, Oliver WC (2008) Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery 63:369–372PubMedGoogle Scholar
  34. Fiss I, Danne M, Stendel R (2007) Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery. Neurol Med Chir (Tokyo) 47:462–467CrossRefGoogle Scholar
  35. Gall RM, Witterick IJ, Shargill NS, Hawke M (2002) Control of bleeding in endoscopic sinus surgery: use of a novel gelatin-based hemostatic agent. J Otolaryngol 31(5):271–274PubMedCrossRefGoogle Scholar
  36. Gazzeri R (2016) Commentary on: efficacy, security and manageability of gelified hemostatic matrix in bleeding control during thoracic and lumbar spine surgery; Floseal versus Surgiflo. J Neurol Surg Part A Cent Eur Neurosurg 77:143–145CrossRefGoogle Scholar
  37. Gazzeri R, Galarza M, Neroni M, Alfieri A, Esposito S (2009) Minimal craniotomy And matrix hemostatic sealant for the treatment of spontaneous supratentorial intracerebral hemorrhage. J Neurosurg 110:939–942PubMedCrossRefGoogle Scholar
  38. Gazzeri R, Galarza M, Neroni M, Alfieri A, Giordano M (2011) Hemostatic matrix sealant in neurosurgery: a clinical and imaging study. Acta Neurochir 153:148–154PubMedCrossRefGoogle Scholar
  39. Gazzeri R, Galarza M, Alfieri A (2012) The safety and biocompatibility of gelatin hemostatic matrix [Floseal and Surgifo] in neurosurgical procedures. Surg Technol Int 22:49–54PubMedGoogle Scholar
  40. Gazzeri R, Galarza M, Alfieri A (2013) Use of gelatin sponge and matrix hemostatics sealant in neurosurgery. Gelatin: production, applications and health implications (Chap. 7), pp 123–136Google Scholar
  41. Gazzeri R, De Bonis C, Galarza M (2014) Use of a thrombin-gelatin hemostatic matrix [Surgiflo] in spinal surgery. Surg Technol Int 25:280–285PubMedGoogle Scholar
  42. Gazzeri R, Galarza M, Conti C, De Bonis C (2017) Incidence of thromboembolic events after use of gelatin-thrombin-based hemostatic matrix during intracranial tumor surgery. Neurosurg RevGoogle Scholar
  43. Gong EM, Zorn KC, Gofrit ON, Lucioni A, Orvieto MA, Zagaja GP, Shalhav AL (2007) Early laparoscopic management of acute postoperative hemorrhage after initial laparoscopic surgery. J Endourol 21(8):872–878PubMedCrossRefGoogle Scholar
  44. Gorry A, Morelli ML, Olowu O, Shahid A, Odejinmi F (2011) Laparoscopic management of abdominal ectopic pregnancy using Floseal hemostatic matrix. Int Fed Gynecol ObstetGoogle Scholar
  45. Guzzo TJ, Pollock RA, Forney A, Aggarwal P, Matlaga BR, Allaf ME (2009) Safety and efficacy of a surgeon-prepared gelatin hemostatic agent compared with Floseal for hemostasis in laparoscopic partial nephrectomy. J Endourol 23(2):279–282PubMedCrossRefGoogle Scholar
  46. Han LY, Schimp V, Oh C, Ramirez PT (2004) A gelatin matrix-thrombin tissue sealant (FloSeal®) application in the management of groin breakdown after inguinal lymphadenectomy for vulvar cancer. Int J Gynecol Cancer 14:621–624PubMedCrossRefGoogle Scholar
  47. Henkel A, Cooper RA, Ward KA, Bova D, Yao K (2008) Malignant-appearing microcalcifications at the lumpectomy site with the use of Floseal Hemostatic sealant. AJR 191:1371–1373PubMedCrossRefGoogle Scholar
  48. Hick EJ, Morey AF, Harris RA, Morris MS (2005) Gelatin matrix treatment of complex renal injuries in a porcine model. J Urol 173:1801–1804PubMedCrossRefGoogle Scholar
  49. Hobday CD, Milam MR, Milam RA, Eusher E, Brown J (2009) Postoperative Small Bowel Obstruction associated with use of hemostatic agents. J Minim Invasive Gynecol 16(2):224–226PubMedCrossRefGoogle Scholar
  50. Hoffmann NE, Siddiqui SA, Agarwal S, McKellar SH, Kurtz HJ, Gettman MT, Ereth MH (2009) Choice of hemostatic agent influences adhesion formation in a rat cecal adhesion model. J Surg Res 155:77–81PubMedCrossRefGoogle Scholar
  51. Hong YM, Loughlin KR (2006) The use of hemostatic agents and sealants in urology. J Urol 176:2367–2374PubMedCrossRefGoogle Scholar
  52. Jameson M, Gross CW, Kountakis SE (2006) Floseal use in endoscopic sinus surgery: effect on postoperative bleeding and synechia formation. Am J Otolaryngol-Head Neck Med Surg 27:86–90Google Scholar
  53. Jo SH, Mathiasen RA, Gurushanthaiah D (2007) Prospective, randomized, controlled trial of a hemostatic sealant in children undergoing adenotonsillectomy. Otolaryngol-Head Neck Surg 137(454):458Google Scholar
  54. Jorgensen S, Bascom DA, Partsafas A, Wax MK (2003) The effect of 2 sealants (FloSeal and Tisseel) on fasciocutaneous flap revascularization. Arch Facial Plast Surg 5:399–402PubMedCrossRefGoogle Scholar
  55. Kaufmann OG, Sountoulides P, Kaplan A, Louie M, McDougall E, Clayman R (2009) Skin treatment and tract closure for tubeless percutaneous nephrolithotomy: university of California, Irvine, technique. J Endourol 23(10):1739–1741PubMedCrossRefGoogle Scholar
  56. Kaul S, Laungani R, Sarle R, Stricker H, Peabody J, Littleton R, Menon M (2007) Da Vinci-assisted robotic partial nephrectomy: technique and results at a mean of 15 months of follow up. Eur Urol 51:186–192PubMedCrossRefGoogle Scholar
  57. Kaushik V, Tahery J, Malik TH, Jones PH (2003) new surgical adjuncts in the treatment of rhinophyma: the mycrodebrider and Floseal®. J Laryngol Otol 117:551–552PubMedCrossRefGoogle Scholar
  58. Kheirabadi BS, Field-Ridley A, Pearson R, MacPhee M, Drohan W, Tuthill D (2002) Comparative study of the efficacy of the common topical hemostatic agents with fibrin sealant in a rabbit aortic anastomosis model. J Surg Res 106:99–107PubMedCrossRefGoogle Scholar
  59. Kim IY, Eichel L, Edwards R, Uribe C, Chou DS, Abdelshehid C, Ahlering M, White S, Woo E, McDougall E, Clayman RV (2007) Effects of commonly used hemostatic agents on the porcine collecting system. J Endourol 21(6):652–654PubMedCrossRefGoogle Scholar
  60. Kim HJ, Fraser MR, Kahn B, Lyman S, Figgie MP (2012) The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg 94(13):1160–1165PubMedCrossRefGoogle Scholar
  61. Klemcke HG (2006) Evaluation of FloSeal as a potential intracavitary hemostatic agent. J TRAUMA® Inj Infect Crit Care 60(2):385–389CrossRefGoogle Scholar
  62. L’Esperance JO, Sung JC, Marguet CG, Maloney ME, Springhart WP, Preminger GM, Alabala DM (2005) Controlled survival study of the effects of Tisseel or o combination of Floseal and Tisseel on major vascular injury and major collecting-system injury during partial nephrectomy in a porcine model. J Endourol 19(9):114–1121Google Scholar
  63. Landi A, Gregori F, Marotta N, Delfini R (2016) Comparative analysis about efficacy, security and manageability of gelified hemostatic matrix in bleeding control during thoracic and lumbar spine surgery: Floseal versus Surgiflo. J Neurosurg Surg Part A Cent Eur Neurosurg 77(2):139–143Google Scholar
  64. Law LW, Chor CM, Leung TY (2010) Use of hemostatic gel in postpartum hemorrhage due to placenta previa. Obstet Gynecol 116(2):528–530PubMedCrossRefGoogle Scholar
  65. Lee DI, Clayman RV (2004) Use of gelatin matrix to rapidly repair diaphragmatic injury during laparoscopy. Urology 63:419PubMedCrossRefGoogle Scholar
  66. Lee DI, Uribe C, Eichel L, Khonsari S, Basilote J, Park HK, Li CC, McDougall EM, Clayman RV (2004) Sealing percutaneous nephrolithotomy tracts with gelatin matrix hemostatic sealant: initial clinical use. J Urol 171:575–578PubMedCrossRefGoogle Scholar
  67. Lee L, Henderson R, Baig K (2014) Successful treatment of aortic root rupture following transcatheter aortic valve implantation in a heavily calcified aorta: a novel approach to a serious complication. Catheter Cardiovasc Interv 84:303–305PubMedCrossRefGoogle Scholar
  68. Lemmer R, Albrech M, Bauer G (2012) Use of Floseal hemostatic matrix in a patient with severe postpartum hemorrhage. J Obstet Gynaecol Res 38(2):435–437PubMedCrossRefGoogle Scholar
  69. Lewis KM, Atlee HD, Mannone AJ, Dwyer J, Lin L, Goppelt A, Redl H (2013) Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Invest Surg 26:141–148PubMedPubMedCentralCrossRefGoogle Scholar
  70. Lewis KM, Atlee H, Mannone A, Lin L, Goppelt A (2015) Efficacy of hemostatic matrix and microporous polysaccharide hemospheres. J Surg Res 193:825–830PubMedCrossRefGoogle Scholar
  71. Li R, Louie MK, Lee HJ, Osann K, Pick DL, Santos R, Mc Dougall EM, Clayman RV (2010) Prospective randomized trial of three different methods of nephrostomy tract closure after percutaneous nephrolithotripsy. BJU Int 107:1660–1665PubMedCrossRefGoogle Scholar
  72. Maccabee MS, Trune DR, Hwang PH (2003) Effects of topically applied biomaterials on paranasal sinus mucosal healing. Am J Rhinol 17(4):203–207PubMedCrossRefGoogle Scholar
  73. Madhuri TK, Tailor A, Butler-Manuel S (2010) Use of surgical sealant in debulking surgery for advanced ovarian carcinoma—case report. Eur J Gynecol Oncol 31(5):582–583Google Scholar
  74. Madi R, Wolf JS (2009) Single-setting bilateral hand-assisted laparocopic partial nephrectomy. J Endourol 23(6):929–932PubMedCrossRefGoogle Scholar
  75. Martinez C, Rosen R, Cohen H, Ruiz CE (2010) A novel method for closing the percutaneous transapical access tract using coils and gelatin matrix. J Invasive Cardiol 22:107–109Google Scholar
  76. Mathiasen RA, Cruz RM (2004) Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy. Otolaryngol-Head Neck Surg 131(5):601–605PubMedCrossRefGoogle Scholar
  77. Mathiasen RA, Cruz RM (2005) Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Laryngoscope 115:899–902PubMedCrossRefGoogle Scholar
  78. Moriarty KT, Premila S, Bulmer PJ (2008) Use of FloSeal™ hemostatic gel in massive obstetric haemorrhage: a casa report. BJOG 115:793–795PubMedCrossRefGoogle Scholar
  79. Mozet C, Prettin C, Dietze M, Fickweiler U, Dietz A (2012) Use of Floseal and effects on wound healing and pain in adults undergoing tonsillectomy: randomised comparison versus electrocautery. Eur Arch Otorhinolaryngol 269:2247–2254PubMedCrossRefGoogle Scholar
  80. Nadler RB, Perry KT, Smith ND (2009) Hybrid laparoscopic and robotic ultrasound-guided radiofrequency ablation-assisted clampless partial nephrectomy. Urology 74(1):202–205PubMedCrossRefGoogle Scholar
  81. Nasso G, Piancone F, Bonifazi R, Romano V, Visicchio G, De Filippo CM, Impiombato B, Fiore F, Bartolomucci F, Alessandrini F, Speziale G (2009) Prospective, randomized clinical trial of the FloSeal Matrix sealant in cardiac surgery. Ann Thorac Surg 88:1520–1526PubMedCrossRefGoogle Scholar
  82. Oz MC, Cosgrove III DM, Badduke BR, Hill JD, Flannery MR, Palumbo R, Nina Topic for The Fusion Matrix Study Group (2000) Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 69:1376–1382Google Scholar
  83. Pace G, Saldutto P, Vincentini C, Miano L (2010) Haemostatic in surgery and our experience in the enucleoresection of renal cell carcinoma. World J Oncol 8:37CrossRefGoogle Scholar
  84. Partezani Helito C, Gomes Gobbi R, Machado Castrillon L, Bremer Hinkel B, Pécora JR, Camanho GL (2013) Comparison of Floseal® and electrocautery in hemostasis after total knee arthroplasty. Acta Ortophaedic Bras 21(6):320–322CrossRefGoogle Scholar
  85. Partsafas AW, Bascom DA, Jorgensen SA, Wax MK (2004) Effects of Tisseel and Floseal on primary ischemic time in a rat fasciocutaneous free flap model. Laryngoscope 114:301–304PubMedCrossRefGoogle Scholar
  86. Prowse S, Kelly G (2010) The oozing tracheostomy—a novel application for FloSeal™Google Scholar
  87. Pursifull NF, Morris MS, Harris RA, Morey AF (2006) Damage control management of experimental grade 5 renal injuries: further evaluation of FloSeal gelatin matrix. J TRAUMA® Inj Infect Crit Care 60(2):346–350CrossRefGoogle Scholar
  88. Renkens KL Jr, Payner TD, Leipzig TJ, Feuer H, Morone MA, Koers JM, Lawson KJ, Lentz R, Shuey H Jr, Conaway GL, Anderson GBJ, Hs An, Hickey M, Rondinone JF, Shargill NF (2001) A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. SPINE 26(15):1645–1650PubMedCrossRefGoogle Scholar
  89. Reuthenbuch O, Lachat ML, Vogt P, Schurr U, Turina M (2000) Floseal®: a new hemostyptic agent in peripheral vascular surgery. VASA 29:204–206CrossRefGoogle Scholar
  90. Richter F, Schnorr D, Deger S, Türk I, Roigas J, Wille A, Loening SA (2003) Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant. Urology 61(1):73–77PubMedCrossRefGoogle Scholar
  91. Rouach Y, Delongchamps NB, Patey N, Fontaine E, Timsit MO, Thiounn N, Méjean A (2009) Suture or hemostatic agent during laparoscopic partial nephrectomy? A randomized study using a hypertensive porcine model. Urology 73(1):172–177PubMedCrossRefGoogle Scholar
  92. Safaee M, Sun MZ, Oh T, Aghi MK, Berger MS, McDermott MW, Parsa AT, Bloch O (2014) Use of thrombin-based hemostatic matrix during meningioma resection: a potential risk factor for perioperative thromboembolic events. Clin Neurol Neurosurg 119:116–120PubMedCrossRefGoogle Scholar
  93. Seyednejad H, Imani M, Jamieson T, Seifalian M (2008) Topical hemostatic agents. Br J Surg 95:1197–1225PubMedCrossRefGoogle Scholar
  94. Shashoua AR, Gill D, Barajas R, Dini M, August C, Kirshenbaum GL, Escuardro L (2009) Caseating granulomata caused by hemostatic agent posing as metastatic leiomyosarcoma. J Soc Laparoendosc Surg 13:226–228Google Scholar
  95. Shire MG, Tabaee A, Hsu AK, Rickert S, Close LG (2007) Synechia formation after endoscopic sinus surgery and middle turbinate medialization with and without Floseal. Am J Rhinol 21(2):174–179CrossRefGoogle Scholar
  96. Soyka MB, Nikolaou G, Rufibach K, Holzmann D (2011) On the effectiveness of treatment options in epistaxis: an analysis of 678 interventions. Rhinology 49:474–478PubMedGoogle Scholar
  97. Stevens AC, Stevens D (2009) Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year. BJU Int 103:994–995PubMedGoogle Scholar
  98. Suzuki Y, Vellinga TT, Istre O, Einarsson JI (2010) Small Bowel Obstruction associated with use of a gelatin-thrombin matrix sealant (FloSeal) after laparoscopic gynecologic surgery. J Minim Invasive Gynecol 17(5):641–645PubMedCrossRefGoogle Scholar
  99. Tabata K, Watanabe M, Naruishi K, Edamura K, Satoh T, Yang G, Fattah EA, Wang J, Goltsov A, Floryk D, Soni SD, Kadmon D, Thompson TC (2009) Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer. Prostate Cancer Prostatic Dis 12:301–309PubMedCrossRefGoogle Scholar
  100. Tackett SM, Calcaterra D, Magee G, Lattouf OM (2014) Real-world outcomes of hemostatic matrices in cardiac surgery. J Cardiothorac Vasc Anesth 28(6):1558–1565PubMedCrossRefGoogle Scholar
  101. Tan BK, Chandra RK (2010) Postoperative prevention and treatment of complications after sinus surgery. Otolaryngology 43:769–779Google Scholar
  102. Testini M, Marzaioli R, Lissidini R, Lippolis A, Logoluso F, Gurrado A, Lardo D, Poli E, Piccinni G (2009) The effectiveness of Floseal® matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study. Langenbecks Arch Surg 394:837–842PubMedCrossRefGoogle Scholar
  103. Thomas PJ, Trawfic SN (2009) Eosinophil-rich inflammatory response to FloSeal hemostatic matrix presenting as postoperative pelvic pain. Am J Obstet Gynecol 11–12Google Scholar
  104. Tonante A, Lo Schiavo MG, Bonanno L et al (2006) Hemorragic complications in thyroid surgery. Control of bleeding from retroneural vessels using collagen and thrombine gelatin granules. Chir Ital 58:61–68PubMedGoogle Scholar
  105. Triaca V, Zagha RM, Libertino JA (2005) Does Thrombin sealant allow nephron-sparing surgery with no renal artery occlusion? A description of technique and initial results. BJU Int 95:1273–1275PubMedCrossRefGoogle Scholar
  106. Ujam A, Awad Z, Wong G, Tatla T, Farrell R (2011) Safety trial of Floseal® hemostatic agent in head and neck surgery. Ann R Coll Surg Engl 94:336–339CrossRefGoogle Scholar
  107. Uribe CA, Eichel L, Khonsari S, Finley DS, Basillote J, Park HK, Li CC, Abdelshehid C, Lee DI, McDougall EM, Clayman RV (2005) What happens to hemostatic agents in contact with urine? An in vitro study. J Endourol 19(3):312–317PubMedCrossRefGoogle Scholar
  108. Valentine R, Wormald PJ, Sindwani R (2009) Advances in absorbable biomaterials and nasal packing. Otolaryngology 42:813–828Google Scholar
  109. Valentine R, Boase S, Jervis-Bardy J, Dones Cabral JD, Robinson S, Wormald PJ (2011) The efficacy of hemostatic techniques in the sheep model of carotid artery injury. Int Forum Allergy Rhinol 1(2):118–122PubMedCrossRefGoogle Scholar
  110. Velyvis JH (2015) Gelatin matrix use reduces postoperative bleeding after total knee arthroplasty. Orthopedics 38(2):118–123CrossRefGoogle Scholar
  111. Waldert M, Remzi M, Klatte T, Klinger HC (2011) Floseal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomy. J Endourol 25(6):969–973PubMedCrossRefGoogle Scholar
  112. Wang C, Han Z, Zhang T, Ma JX, Jiang X, Wang Y, Ma XI (2014) The efficacy of a thrombin-based hemostatic agent in primary total knee arthroplasty: a meta-analysis. J Orthop Surg Res 9:90PubMedPubMedCentralCrossRefGoogle Scholar
  113. Weaver FA, Hood DB, Zatina M, Messina L, Badduke B, Francisco San, Fremont California, Baltimore Maryland (2002) gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 16(3):286–293PubMedCrossRefGoogle Scholar
  114. Wille AH, Tüllmann M, Roigas J, Loening SA, Deger S (2006) Laparoscopic partial nephrectomy in renal cell cancer—results and reproducibility by different surgeons in a high volume laparoscopic center. Eur Urol 49:337–343PubMedCrossRefGoogle Scholar
  115. Wille AH, Johannsen M, Miller K, Deger S (2009) Laparoscopic partial nephrectomy using Floseal for hemostasis: technique and experiences in 102 patients. Surg Innov 14(4):306–312CrossRefGoogle Scholar
  116. Williams MR, D’Ambra AB, Beck JR, Spanier TB, Morales DLS, Helman DN, Oz MC (2000) A randomized trial of antithrombin concentrate for treatment of heparine resistance. Ann Thorac Surg 70:873–877PubMedCrossRefGoogle Scholar
  117. Wohlmuth CT, Merced JD (2011) Gelatin-thrombin hemostatic matrix in the management of placenta site postpartum hemorrhage. J Reprod Med 56(5–6):271–273PubMedGoogle Scholar
  118. Zeltser I, Dugi D, Gupta A, Park S, Kabbani W, Cadeddu J (2008) Does topical hemostatic agent have an adverse effect on the function of the prostatic neurovascular bundle? BJU Int 102:1005–1007PubMedCrossRefGoogle Scholar
  119. Zorn KC, Gong EM, Orvieto MA, Gofrit ON, Mikhail AA, Shalhav AL (2007) Impact of collecting-system repair during laparoscopic partial nephrectomy. J Endourol 31(3):315–320CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Roberto Gazzeri
    • 1
    Email author
  • Marcelo Galarza
    • 2
  • Marika Morabito
    • 1
  • Alex Alfieri
    • 3
  1. 1.Department of NeurosurgerySan Giovanni Addolorata HospitalRomeItaly
  2. 2.Department of NeurosurgeryHospital Universitario Virgen de la ArrixacaMurciaSpain
  3. 3.Department of Neurosurgery and Spinal SurgeryRuppiner Kliniken GmbHNeuruppinGermany

Personalised recommendations